Gerard Evan
From Wikipedia, the free encyclopedia
Born17 August 1955[1]
KnownforDisease Models & Mechanisms
AwardsFellow of the Royal Society (2004)
FMedSci (1999)[2]
PhD (1982)
FMedSci (1999)[2]
PhD (1982)
Gerard Evan | |
|---|---|
| Born | 17 August 1955[1] |
| Alma mater | St Peter's College, Oxford King's College, Cambridge[1] |
| Known for | Disease Models & Mechanisms |
| Awards | Fellow of the Royal Society (2004) FMedSci (1999)[2] PhD (1982) |
| Scientific career | |
| Fields | Cancer[3][4][5][6][7][8] Disease biology Myc regulator gene[9] p53 tumour suppressor[10] |
| Institutions | University of Oxford University of Cambridge UCSF[1][11] Cancer Research UK[12] Ensemble Therapeutics |
| Thesis | Monoclonal antibodies as reagents for the analysis of cell surfaces (1982) |
| Website | www labmed |
Gerard Ian Evan FRS, FMedSci (born 17 August 1955) is a British biologist and, since May 2022, Professor of Cancer Biology at King's College London and a principal group leader in the Francis Crick Institute. Prior to this he was Sir William Dunn Professor of Biochemistry and Head of Biochemistry at the University of Cambridge (2009–2022).[11]
Evan was educated at St Peter's College, Oxford, where he studied Biochemistry, and King's College, Cambridge, where he was awarded his PhD in 1982 for research using Monoclonal antibodies.[1][13]
